Redmile Group, LLC Repare Therapeutics Inc. Transaction History

Redmile Group, LLC

$1.53 Billion
Q3 2024

A detailed history of Redmile Group, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 1,942,555 shares of RPTX stock, worth $5.52 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

1,942,555

Previous 1,942,555 -0.0%

Holding current value

$5.52 Million

Previous $6.41 Million 4.24%

% of portfolio

0.44%

Previous 0.42%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.02 - $4.7 $222,715 - $346,610	-73,747 Reduced 3.66%	1,942,555 $6.41 Million
Q1 2024 May 15, 2024	SELL	$4.53 - $8.41 $599,980 - $1.11 Million	-132,446 Reduced 6.16%	2,016,302 $9.5 Million
Q4 2023 Feb 14, 2024	SELL	$3.22 - $11.79 $900,270 - $3.3 Million	-279,587 Reduced 11.51%	2,148,748 $15.7 Million
Q2 2023 Aug 14, 2023	SELL	$8.63 - $12.53 $903,690 - $1.31 Million	-104,715 Reduced 4.13%	2,428,335 $25.7 Million
Q1 2023 May 15, 2023	SELL	$9.32 - $15.06 $1.41 Million - $2.28 Million	-151,346 Reduced 5.64%	2,533,050 $24.9 Million
Q3 2022 Nov 14, 2022	SELL	$11.57 - $15.59 $423,462 - $570,594	-36,600 Reduced 1.35%	2,684,396 $32.6 Million
Q2 2022 Aug 15, 2022	SELL	$8.45 - $14.84 $101,399 - $178,080	-12,000 Reduced 0.44%	2,720,996 $38.1 Million
Q1 2022 May 16, 2022	SELL	$11.38 - $21.88 $642,970 - $1.24 Million	-56,500 Reduced 2.03%	2,732,996 $38.9 Million
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $4.36 Million - $6.23 Million	221,800 Added 8.64%	2,789,496 $58.8 Million
Q3 2021 Nov 15, 2021	SELL	$25.71 - $35.24 $1.46 Million - $2 Million	-56,700 Reduced 2.16%	2,567,696 $67.4 Million
Q2 2021 Aug 16, 2021	SELL	$30.1 - $34.85 $1.24 Million - $1.43 Million	-41,100 Reduced 1.54%	2,624,396 $81.8 Million
Q1 2021 May 17, 2021	BUY	$25.89 - $44.46 $460,842 - $791,388	17,800 Added 0.67%	2,665,496 $81.8 Million
Q4 2020 Feb 16, 2021	BUY	$23.42 - $39.5 $5.68 Million - $9.59 Million	242,722 Added 10.09%	2,647,696 $90.8 Million
Q3 2020 Nov 16, 2020	BUY	$21.55 - $33.92 $405,140 - $637,696	18,800 Added 0.79%	2,404,974 $74 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $73.5 Million - $78.7 Million	2,386,174 New	2,386,174 $74 Million

Others Institutions Holding RPTX

# of Institutions

Shares Held

35.4M

Call Options Held

50K

Put Options Held

300

View Full List

About Repare Therapeutics Inc.

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $119M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

More about RPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account

Redmile Group, LLC Repare Therapeutics Inc. Transaction History